DEW - Why don't you call Dr. Levitt personally or Investor Relations and talk to them about your concerns below. I see no reason why they/he wouldn't talk to you about this. Also, do you think GENR's top management/investor relations reads this board? Thanks to everyone for all of their posts about the R&R presentation....10nis
>> we are toying around with ruminating (about dosing frequencies) before we indeed know the scientific proof of Squalamine’s probable efficacy. <<
We are discussing the dosing frequency and possible subcutaneous administration because Dr. Levitt mentioned these matters in his talk. Our job is to figure out why he did, and I don’t think we have a convincing answer yet.
Market Data 
Markets 
AI
